1900 1717 
Preeclampsia Panel 2 (for 2nd and 3rd trimester) allows mothers to take preeclampsia tests, preventing the risk of eclampsia developing and ensuring that mother and baby are safe and well prepared for labor.
– Sample Type: Blood | Urine
– Age: Pregnant women where the gestational age in the 20-34 weeks| Administered by a doctor.
– Results: 24 hours from when the laboratory receives the sample.
– Note: It is not necessary to fast before taking samples for testing.
1. Overview of Preeclampsia Panel 2 (for 2nd and 3rd trimester)
Preeclampsia usually appears from the 20th week of pregnancy. If not detected and treated in time, it may lead to eclampsia (a generalized convulsion condition and the leading cause of death in pregnant women). The condition has a worldwide mortality rate of up to 14% (according to the Ministry of Health of Vietnam). Signs suggestive of preeclampsia include headache, blurred vision, vomiting, and swelling of the limbs.
Preeclampsia occurs when the mother’s process of producing blood vessels to feed the fetus occurs abnormally, with common causes being:
– The mother’s ability to produce blood vessels to distribute to the fetus reduces (manifested by low PLGF test index), leading to insufficient blood volume necessary for the baby’s normal development.
– The mother’s blood vessels are broken due to high blood pressure, causing a decrease or lack of blood supply to the fetus.
– Mother has an immune system disease.
– Due to genes.
Preeclampsia Panel 2 (for 2nd and 3rd trimester) helps determine the mother’s ability to produce enough blood vessels to feed the fetus, supporting the mother and baby’s careful preparation for a safe birth and postpartum process and checking for protein in the urine to diagnose preeclampsia.
2. Which Tests Will You Take in Preeclampsia Panel 2 (for 2nd and 3rd trimester)?
The test package deploys 3 types of tests to help detect and assess health risks, including:
– PLGF test: The mother’s ability to produce blood vessels tends to naturally decrease in the last 3 months of pregnancy. If the reduction in PLGF is still within the allowable threshold, it will not affect the mother and baby. Conversely, if the total threshold PLGF decreases, it can lead to anemia, with the mother not having enough blood supply to feed the baby, causing a risk of stillbirth.
– sFlt-1 test: To determine an abnormal decrease (if any) of the unique number of PLGFs, the sFlt-1 test should be performed to find the ratio between sFlt-1: PLGF. sFlt-1 is the opposite of PLGF. When decreased, it shows that the mother is producing blood at a permissible level. However, if sFlt-1 increases (usually in the last 3 months), the blood production exceeds the stable threshold, causing potential harm to the mother and baby.
Therefore, it is important to calculate the ratio between these two substances to check the mother’s vascular production status, identifying any abnormalities in the process of reducing PLGF that may limit the mother’s ability to produce blood to feed her child.
– Urinalysis: Based on the test results from urine biochemistry, doctors can detect kidney diseases and proteins (protein in urine) that can cause preeclampsia.
3. Why Test At Diag Laboratories?
– Possessing certificates of test quality such as ISO 15189 and EQAb.
– Deploy a variety of tests to meet the needs of patients. In addition, Diag uses modern vacuum blood collection techniques to limit pain and reduce the risk of rupturing veins or red blood cells.
– If you are far from our centers or busy with work, Diag Laboratories offers a home sampling service. Your sample will be collected at home and you can track your profile information online and receive your results via SMS.
Preeclampsia Panel 2 (for 2nd and 3rd trimester) provides tests that help diagnose the risk of preeclampsia, supporting mother and baby in preparing thoroughly for the birth process, as well as to be safe after birth. Do not hesitate to call the hotline on 1900 1717 to receive advice from Diag staff and make an appointment as soon as possible.